200 related articles for article (PubMed ID: 26809941)
21. Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs.
Day E; Broder T; Bruneau J; Cruse S; Dickie M; Fish S; Grillon C; Luhmann N; Mason K; McLean E; Trooskin S; Treloar C; Grebely J
Int J Drug Policy; 2019 Apr; 66():87-93. PubMed ID: 30743093
[TBL] [Abstract][Full Text] [Related]
22. Language support for linguistic minority chronic hepatitis B/C patients: an exploratory study of availability and clinicians' perceptions of language barriers in six European countries.
Falla AM; Veldhuijzen IK; Ahmad AA; Levi M; Richardus JH
BMC Health Serv Res; 2017 Feb; 17(1):150. PubMed ID: 28219385
[TBL] [Abstract][Full Text] [Related]
23. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*.
Hatzakis A; Wait S; Bruix J; Buti M; Carballo M; Cavaleri M; Colombo M; Delarocque-Astagneau E; Dusheiko G; Esmat G; Esteban R; Goldberg D; Gore C; Lok AS; Manns M; Marcellin P; Papatheodoridis G; Peterle A; Prati D; Piorkowsky N; Rizzetto M; Roudot-Thoraval F; Soriano V; Thomas HC; Thursz M; Valla D; van Damme P; Veldhuijzen IK; Wedemeyer H; Wiessing L; Zanetti AR; Janssen HL
J Viral Hepat; 2011 Sep; 18 Suppl 1():1-16. PubMed ID: 21824223
[TBL] [Abstract][Full Text] [Related]
24. [Clinical features and diagnosis of hepatitis B, C and D. Acute or chronic process?].
Jochum C; Gerken G
Pharm Unserer Zeit; 2011 Jan; 40(1):30-5. PubMed ID: 21194079
[No Abstract] [Full Text] [Related]
25. Can hepatitis C be eradicated in the United States?
Edlin BR; Winkelstein ER
Antiviral Res; 2014 Oct; 110():79-93. PubMed ID: 25110202
[TBL] [Abstract][Full Text] [Related]
26. Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review.
Papatheodoridis GV; Tsochatzis E; Hardtke S; Wedemeyer H
Liver Int; 2014 Nov; 34(10):1452-63. PubMed ID: 24750532
[TBL] [Abstract][Full Text] [Related]
27. Chronic viral hepatitis: always be current!
Hochman JA; Balistreri WF
Pediatr Rev; 2003 Dec; 24(12):399-410. PubMed ID: 14645627
[No Abstract] [Full Text] [Related]
28. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
Papatheodoridis GV; Hatzakis A; Cholongitas E; Baptista-Leite R; Baskozos I; Chhatwal J; Colombo M; Cortez-Pinto H; Craxi A; Goldberg D; Gore C; Kautz A; Lazarus JV; Mendão L; Peck-Radosavljevic M; Razavi H; Schatz E; Tözün N; van Damme P; Wedemeyer H; Yazdanpanah Y; Zuure F; Manns MP
J Viral Hepat; 2018 Mar; 25 Suppl 1():6-17. PubMed ID: 29508946
[TBL] [Abstract][Full Text] [Related]
29. Survey of lived experiences and challenges in hepatitis B management and treatment.
Freeland C; Adjei C; Wallace J; Wang S; Hicks J; Adda D; James C; Cohen C
BMC Public Health; 2024 Apr; 24(1):944. PubMed ID: 38566070
[TBL] [Abstract][Full Text] [Related]
30. 2017 European guideline for the screening, prevention and initial management of hepatitis B and C infections in sexual health settings.
Brook G; Brockmeyer N; van de Laar T; Schellberg S; Winter AJ
Int J STD AIDS; 2018 Sep; 29(10):949-967. PubMed ID: 29716442
[TBL] [Abstract][Full Text] [Related]
31. Patterns of viral hepatitis in Hong Kong.
Leung NW
Br J Hosp Med; 1997 Aug 20-Sep 2; 58(4):166-9. PubMed ID: 9373408
[TBL] [Abstract][Full Text] [Related]
32. Barriers faced by migrants in accessing healthcare for viral hepatitis infection.
Guirgis M; Nusair F; Bu YM; Yan K; Zekry AT
Intern Med J; 2012 May; 42(5):491-6. PubMed ID: 22151101
[TBL] [Abstract][Full Text] [Related]
33. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
[TBL] [Abstract][Full Text] [Related]
34. Informing the design of a national screening and treatment programme for chronic viral hepatitis in primary care: qualitative study of at-risk immigrant communities and healthcare professionals.
Sweeney L; Owiti JA; Beharry A; Bhui K; Gomes J; Foster GR; Greenhalgh T
BMC Health Serv Res; 2015 Mar; 15():97. PubMed ID: 25890125
[TBL] [Abstract][Full Text] [Related]
35. Institute of Medicine recommendations for the prevention and control of hepatitis B and C.
Mitchell AE; Colvin HM; Palmer Beasley R
Hepatology; 2010 Mar; 51(3):729-33. PubMed ID: 20186842
[TBL] [Abstract][Full Text] [Related]
36. Liver disease in Viet Nam: screening, surveillance, management and education: a 5-year plan and call to action.
Gish RG; Bui TD; Nguyen CT; Nguyen DT; Tran HV; Tran DM; Trinh HN;
J Gastroenterol Hepatol; 2012 Feb; 27(2):238-47. PubMed ID: 22098550
[TBL] [Abstract][Full Text] [Related]
37. Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality - results from two surveys (2016).
Aspinall EJ; Hutchinson SJ; Goldberg DJ; Valerio H; Mozalevskis A; Noori T; Duffell E; Tavoschi L
HIV Med; 2018 Feb; 19 Suppl 1():11-15. PubMed ID: 29488708
[TBL] [Abstract][Full Text] [Related]
38. Improving Healthcare Systems to Reduce Healthcare Disparities in Viral Hepatitis.
Chak EW; Sarkar S; Bowlus C
Dig Dis Sci; 2016 Oct; 61(10):2776-2783. PubMed ID: 27234269
[TBL] [Abstract][Full Text] [Related]
39. Limited access to hepatitis B/C treatment among vulnerable risk populations: an expert survey in six European countries.
Falla AM; Veldhuijzen IK; Ahmad AA; Levi M; Hendrik Richardus J
Eur J Public Health; 2017 Apr; 27(2):302-306. PubMed ID: 27542982
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
